Unlock instant, AI-driven research and patent intelligence for your innovation.

Method for preparing lapatinib key intermediates

A technology of lapatinib and intermediates, which is applied in the field of preparation of key intermediates of lapatinib, can solve the problems of high reaction conditions and operation requirements, complicated processes, and high industrial production costs, and achieve good industrialization prospects and reaction conditions Gentle, highly atom-efficient effect

Active Publication Date: 2018-08-07
安庆奇创药业有限公司
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

In the known synthetic route, directly adopt 6-halo-quinazolin-4-one as raw material, prepare with chlorinating agents such as phosphorus trichloride, phosphorus pentachloride, thionyl chloride, phosgene or phosphorus oxychloride The obtained intermediate 6-halogenated-chloroquinazoline, the method directly adopts the expensive 6-halogenated-quinazolin-4-one as a raw material, which causes the high problem of industrial production cost and is not suitable for large-scale industrialization Production, the production process pollutes the environment and safety risks are difficult to control
[0004] Regarding the current preparation methods of lapatinib, although there are many methods for side chain linkage and quinazoline ring formation, there are still complicated processes, high requirements for reaction conditions and operations, expensive starting materials and low atom utilization, heavy metal pollution and Problems such as low yield

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for preparing lapatinib key intermediates
  • Method for preparing lapatinib key intermediates
  • Method for preparing lapatinib key intermediates

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0026] The preparation of embodiment 1, N '-chloroform imine amide (the acetate of compound 2)

[0027] Dissolve formamidine acetate (5.2g, 0.05mol) in 30mL of acetonitrile, then add N-chlorosuccinimide (6.68g, 0.05mol), heat the reaction system to 80°C, and stir for 6h to obtain the reaction The solution was reserved for the next step.

Embodiment 2

[0028] The preparation of embodiment 2,4-hydroxyl-6-nitroquinazoline (compound 5)

[0029] 2-iodo-5-nitrotoluene (10.5g, 0.04mol), copper acetate (0.72g, 0.004mol), tert-butyl hydroperoxide (15.4g, 0.12mol) and potassium carbonate (5.5g, 0.04mol ) was added to the reaction solution obtained in Example 1, the reaction system was heated to 80° C., stirred for 24 h, cooled to room temperature, poured into ice water, filtered, and washed with water to obtain 4-hydroxyl-6-nitroquinazoline ( Compound 5) had 7.13 g of needle crystals, with a yield of 93.3% and a HPLC purity of 99.80%.

Embodiment 3

[0030] The preparation of embodiment 3,4-hydroxyl-6-nitroquinazoline (compound 5)

[0031] 2-iodo-5-nitrotoluene (10.5g, 0.04mol), copper chloride (0.72g, 0.004mol), tert-butyl hydroperoxide (15.4g, 0.12mol) and potassium carbonate (5.5g, 0.04 mol) was added to the reaction solution obtained in Example 1, the reaction system was heated to 90° C., stirred for 24 h, cooled to room temperature, poured into ice water, filtered, and washed with water to obtain 4-hydroxyl-6-nitroquinazoline (Compound 5) needle crystal 6.97g, yield 91.2%, HPLC purity 99.72%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a method for preparing lapatinib key intermediates. The method includes steps of (1), carrying out chlorination on formamidine or salt of the formamidine and N-chlorosuccinimide to prepare compounds 2 or salt of the compounds 2; (2), carrying out reaction on the compounds 2 or the salt of the compounds 2 and compounds 3 to obtain compounds 5; (3), carrying out reaction on the compounds 5 and thionyl chloride to obtain compounds 6 which are the lapatinib key intermediates. The method has the advantages of inexpensive and easily available starting materials, simplified steps, high atom utilization rate, mild reaction conditions, high yield, suitability for industrial production and the like.

Description

technical field [0001] The invention belongs to the technical field of medicine and chemical industry, and in particular relates to a preparation method of a lapatinib key intermediate. Background technique [0002] As an antitumor drug, the chemical name of lapatinib (lapatinib) is N-(3-chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-(( (2-(methylsulfonyl)ethyl)amino)methyl)-2-furyl)-4-quinazolinamine di-p-toluenesulfonate, which was approved for marketing by the US FDA in March 2007, is a 4-anilinoquinazoline receptor tyrosine kinase inhibitors for the treatment of advanced or metastatic breast cancer. [0003] 4-Chloro-6-nitroquinazoline is the key intermediate of lapatinib, the preparation method of lapatinib and related intermediates reported in patents WO05046678 and WO020255. In the known synthetic route, directly adopt 6-halo-quinazolin-4-one as raw material, prepare with chlorinating agents such as phosphorus trichloride, phosphorus pentachloride, thionyl chloride,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D239/86C07D405/04
CPCC07D239/86C07D405/04
Inventor 吴学平储贻结
Owner 安庆奇创药业有限公司
Features
  • R&D
  • Intellectual Property
  • Life Sciences
  • Materials
  • Tech Scout
Why Patsnap Eureka
  • Unparalleled Data Quality
  • Higher Quality Content
  • 60% Fewer Hallucinations
Social media
Patsnap Eureka Blog
Learn More